Globe Newswire02.14.22
Anika Therapeutics Inc. has welcomed Sheryl Conley to its Board of Directors.
“We are pleased to have Sheryl join our Board of Directors as Anika executes on its strategy to transform into a leading joint preservation company,” said Cheryl R. Blanchard, Ph.D., president and CEO of Anika. “I have known Sheryl for many years as an innovator and leader in the orthopedic industry and her commercial experience in orthopedics is second to none. She spent more than 25 years at Zimmer in escalating management roles, including as group president across a variety of product segments and geographies, during which she provided key leadership in the development and commercialization of over 50 industry leading brands. We are very excited for her to bring those experiences to the Anika board.”
Conley has more than 35 years of orthopedic and healthcare industry experience, most recently serving as president and CEO of OrthoWorx Inc., and previously as group president, Americas and Global Brand Management, and chief marketing officer for Zimmer Inc. Conley's orthopedic industry knowledge focuses on global brand management, marketing, sales, product development, and operations.
Conley will serve on the Anika board's Audit Committee. This appointment brings the total number of independent directors to seven.
“Adding Sheryl brings a high degree of industry knowledge, including significant experience in operating fully integrated orthopedic businesses, which will help guide Anika through its transformational journey as it becomes a leading joint preservation company. I look forward to working with Sheryl in her new role,” Board Chair Jeff Thompson said.
Conley is currently president and a board member of AcceLINX Inc., a musculoskeletal health business accelerator. She also serves on the Board of Directors for Neuronetics Inc., where she is a member of the Audit and Nominating and Governance Committees. She also chairs Surgalign Inc.'s board, and is also a member of the Audit Committee.
Conley earned a bachelor of science degree in biology and chemistry and an MBA from Ball State University (Indiana).
Anika Therapeutics is a global joint preservation company that creates and delivers advancements in early intervention orthopedic care. The firm operates within the osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies sectors.
“We are pleased to have Sheryl join our Board of Directors as Anika executes on its strategy to transform into a leading joint preservation company,” said Cheryl R. Blanchard, Ph.D., president and CEO of Anika. “I have known Sheryl for many years as an innovator and leader in the orthopedic industry and her commercial experience in orthopedics is second to none. She spent more than 25 years at Zimmer in escalating management roles, including as group president across a variety of product segments and geographies, during which she provided key leadership in the development and commercialization of over 50 industry leading brands. We are very excited for her to bring those experiences to the Anika board.”
Conley has more than 35 years of orthopedic and healthcare industry experience, most recently serving as president and CEO of OrthoWorx Inc., and previously as group president, Americas and Global Brand Management, and chief marketing officer for Zimmer Inc. Conley's orthopedic industry knowledge focuses on global brand management, marketing, sales, product development, and operations.
Conley will serve on the Anika board's Audit Committee. This appointment brings the total number of independent directors to seven.
“Adding Sheryl brings a high degree of industry knowledge, including significant experience in operating fully integrated orthopedic businesses, which will help guide Anika through its transformational journey as it becomes a leading joint preservation company. I look forward to working with Sheryl in her new role,” Board Chair Jeff Thompson said.
Conley is currently president and a board member of AcceLINX Inc., a musculoskeletal health business accelerator. She also serves on the Board of Directors for Neuronetics Inc., where she is a member of the Audit and Nominating and Governance Committees. She also chairs Surgalign Inc.'s board, and is also a member of the Audit Committee.
Conley earned a bachelor of science degree in biology and chemistry and an MBA from Ball State University (Indiana).
Anika Therapeutics is a global joint preservation company that creates and delivers advancements in early intervention orthopedic care. The firm operates within the osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies sectors.